跳至主要内容
临床试验/TCTR20180828010
TCTR20180828010进行中(未招募)2 期

Comparison of Elonide and Nasonex nasal spray for the treatment of perennial allergic rhinitis

HOE Pharmaceuticals Sdn Bhd, Malaysia0 个研究点目标入组 70 人开始时间: 2018年8月28日最近更新:
适应症

试验速览

阶段
2 期
状态
进行中(未招募)
发起方
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 70 Years(—)
性别
All

入选标准

  • Moderate to severe symptoms with history nasal allergy at least 12 months, 2 or more symptoms: rhinorrhea, sneezing, itching, nasal obstruction, confirmed by skin prick test positive with a wheal diameter 3 mm to indoor allergen (mite, cockroach, mold)

排除标准

  • Pregnancy, Upper and lower respiratory tract infection in 2 weeks prior to the study, Other nasal conditions causing nasal obstruction such as severe deviated nasal septum, nasal polyp, Using intranasal or oral steroids within 4 weeks before first visit, Using antihistamine, antileukotrienes within 2 weeks before first visit, Using decongestant within 1 day before first visit

研究者

发起方
HOE Pharmaceuticals Sdn Bhd, Malaysia

相似试验